HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,635 | +22.5% | 16,417 | +16.4% | 0.13% | +27.7% |
| Q2 2023 | $1,200,985 | +4.5% | 14,106 | +1.6% | 0.10% | +2.0% |
| Q1 2023 | $1,149,398 | +18.4% | 13,890 | +12.5% | 0.10% | +28.6% |
| Q4 2022 | $970,777 | +26.2% | 12,343 | +18.8% | 0.08% | -4.9% |
| Q3 2022 | $769,000 | +13.8% | 10,389 | +0.1% | 0.08% | +19.1% |
| Q2 2022 | $676,000 | +30.3% | 10,376 | +26.4% | 0.07% | +44.7% |
| Q1 2022 | $519,000 | +68.0% | 8,211 | +40.7% | 0.05% | +74.1% |
| Q4 2021 | $309,000 | -8.8% | 5,834 | +21.5% | 0.03% | -22.9% |
| Q3 2021 | $339,000 | +24.2% | 4,803 | +17.2% | 0.04% | +29.6% |
| Q2 2021 | $273,000 | +1.9% | 4,098 | +69.5% | 0.03% | -10.0% |
| Q1 2021 | $268,000 | -6.9% | 2,417 | -0.5% | 0.03% | -16.7% |
| Q4 2020 | $288,000 | +42.6% | 2,428 | +4.8% | 0.04% | +24.1% |
| Q3 2020 | $202,000 | +119.6% | 2,317 | +126.5% | 0.03% | +123.1% |
| Q2 2020 | $92,000 | 0.0% | 1,023 | +11.3% | 0.01% | -18.8% |
| Q1 2020 | $92,000 | – | 919 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |